Concepedia

Anne Paccaly

AP

25

Publications

1.4K

Citations

18

H-Index

2006

Active since

Affiliations

Regeneron (United States)(Current)

Sanofi (United States)

Sanofi (France)

Sarah Cannon

South Texas Accelerated Research Therapeutics

Anne Paccaly is an author at Regeneron (United States) specializing in medicine, immunology, and immunotherapy.

ORCID

Top concepts

Publications per year

2006–2024

25

Publications

25

Cemiplimab plus chemotherapy versus chemotherapy alone in non-small cell lung cancer: a randomized, controlled, double-blind phase 3 trial

Miranda Gogishvili, Tamar Melkadze, Tamta Makharadze et al. · Nature Medicine · 2022 · 268 citations · Full text

Early bactericidal activity of delamanid (OPC-67683) in smear-positive pulmonary tuberculosis patients

Andreas H. Diacon, Rodney Dawson, M. Hanekom et al. · The International Journal of Tuberculosis and Lung Disease · 2011 · 203 citations

Safety and tolerability of subcutaneous sarilumab and intravenous tocilizumab in patients with rheumatoid arthritis

Paul Emery, Juan Rondon, Janie Parrino et al. · Lara D. Veeken · 2018 · 123 citations · Full text

Quantification of Apixaban's Therapeutic Utility in Prevention of Venous Thromboembolism: Selection of Phase III Trial Dose

Tarek A. Leil, Yilin Feng, L Zhang et al. · Clinical Pharmacology & Therapeutics · 2010 · 92 citations

Disease–Drug Interaction of Sarilumab and Simvastatin in Patients with Rheumatoid Arthritis

Eun Bong Lee, Nikki Daskalakis, Christine Xu et al. · Clinical Pharmacokinetics · 2016 · 76 citations · Full text

Rows per page

1–5 of 25